|
|
SECURITIES AND EXCHANGE COMMISSION |
|
|
|
Washington, D.C. 20549 |
|
|
|
|
|
|
|
SCHEDULE 13D |
|
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. )*
QLT INC.
(Name of Issuer)
Common Shares without par value
(Title of Class of Securities)
746927102
(CUSIP Number)
Auxilium Pharmaceuticals, Inc.
640 Lee Road
Chesterbrook, PA 19087
Attn: Andrew I. Koven
(484) 321-5900
Copies to:
Skadden, Arps, Slate, Meagher & Flom LLP
Four Times Square
New York, NY 10036
Attn: Paul T. Schnell, Esq.
Thomas W. Greenberg, Esq.
(212) 735-3000
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 25, 2014
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-l(e), 240.13d-l(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
CUSIP No. 746927102 | |||||
|
| |||||
|
|
1 |
Name of Reporting Person | |||
|
| |||||
|
|
2 |
Check the Appropriate Box if a Member of a Group | |||
|
|
|
(a) |
o | ||
|
|
|
(b) |
o | ||
|
| |||||
|
|
3 |
SEC Use Only | |||
|
| |||||
|
|
4 |
Source of Funds | |||
|
| |||||
|
|
5 |
Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | |||
|
| |||||
|
|
6 |
Citizenship or Place of Organization | |||
|
| |||||
|
Number of |
7 |
Sole Voting Power | |||
|
| |||||
|
8 |
Shared Voting Power | ||||
|
| |||||
|
9 |
Sole Dispositive Power | ||||
|
| |||||
|
10 |
Shared Dispositive Power | ||||
|
| |||||
|
|
11 |
Aggregate Amount Beneficially Owned by Each Reporting Person | |||
|
| |||||
|
|
12 |
Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares o | |||
|
| |||||
|
|
13 |
Percent of Class Represented by Amount in Row (11) | |||
|
| |||||
|
|
14 |
Type of Reporting Person | |||
|
(1) |
Beneficial ownership of approximately 32.2% of outstanding Shares (as defined herein) is being reported hereunder solely because Auxilium Pharmaceuticals, Inc. (“Auxilium”) may be deemed to have beneficial ownership of such shares as a result of entering into the Voting Agreements (as defined herein) described in this Schedule 13D. Pursuant to Rule 13d-4, neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission by Auxilium that it is the beneficial owner of any Shares for purposes of Section 13(d) of the Exchange Act, or for any other purpose, and such beneficial ownership is expressly disclaimed. The calculation of the approximately 32.2% beneficial ownership is based on (i) 16,434,436 Shares beneficially owned by the shareholders that are party to the Voting Agreements as of June 25, 2014, and (ii) 51,081,878 Shares outstanding as of June 25, 2014 (as represented by QLT Inc. in the Merger Agreement referred to in this Schedule 13D). |
SCHEDULE 13D
Introductory Note
This Schedule 13D (this “Statement”) is being filed as an original filing with the Securities and Exchange Commission (the “SEC”) by Auxilium Pharmaceuticals, Inc., a Delaware corporation (“Auxilium”), in connection with certain Voting Agreements, each dated as of June 25, 2014 (the “Voting Agreements”), by and between Auxilium and Axial Capital Management, LLC, Kingstown Capital Partners, LLC and Visium Balanced Master Fund, Ltd. (each a “Shareholder” and collectively, the “Shareholders”) of QLT Inc. (“QLT”). The Voting Agreements were entered into in connection with the signing of an Agreement and Plan of Merger, dated as of June 25, 2014 (the “Merger Agreement”), by and among Auxilium, QLT, QLT Holding Corp., a Delaware corporation and wholly owned subsidiary of QLT (“HoldCo”), and QLT Acquisition Corp., a Delaware corporation and wholly owned subsidiary of HoldCo (“AcquireCo”). Pursuant to the Merger Agreement, AcquireCo will merge with and into Auxilium (the “Merger”). As a result of the Merger, the separate corporate existence of AcquireCo will cease and Auxilium will continue as the surviving corporation.
Item 1. Security and Issuer
This Statement relates to common shares, no par value, of QLT (the “Shares”). The name of the issuer is QLT Inc. The principal executive offices of QLT are located at 250-887 Great Northern Way, Vancouver, B.C., Canada V5T 4T5.
Item 2. Identity and Background
(a) – (c), (f) This Statement is being filed by Auxilium.
Auxilium is a corporation organized under the laws of the state of Delaware. Auxilium is a publicly listed, fully integrated specialty biopharmaceutical company. The address of the principal executive offices of Auxilium is 640 Lee Road, Chesterbrook, PA 19087.
The name, business address, present principal occupation or employment and citizenship of each director and executive officer of Auxilium are set forth on Schedule A hereto and are incorporated herein by reference.
(d) – (e) During the last five years, Auxilium has not, and to the best knowledge of Auxilium, none of the persons listed on Schedule A hereto has, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in such person being subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
As more fully described in Item 4 hereof, as an inducement for Auxilium to enter into the Merger Agreement, and in consideration thereof, the Shareholders entered into the Voting Agreements with Auxilium pursuant to which each Shareholder agreed to vote all of its Shares and any other shares of capital stock of QLT owned, beneficially or of record, as set forth in Schedule A of each Voting Agreement (its “Owned Securities”) in favor of the approval of the Merger, pursuant to which the shares of Auxilium will be converted into the right to receive common shares of QLT (such transactions, together with any other transaction contemplated by the Merger Agreement, the “Transaction”). The Shares to which this Statement relates have not been purchased by Auxilium, and thus no funds have been used for such purpose. Other than the consideration to be paid by Auxilium pursuant to the Merger Agreement in accordance with the terms and conditions of the Merger Agreement, Auxilium has paid no funds or other consideration in connection with the execution and delivery of the Voting Agreements. For a description of
the Voting Agreements and the Merger Agreement, see Item 4 below, which description is incorporated by reference in response to this Item 3.
Item 4. Purpose of the Transaction
(a) – (j)
Merger Agreement
As set forth in the Introductory Note, on June 25, 2014, QLT, Auxilium, HoldCo and AcquireCo entered into the Merger Agreement (attached hereto as Exhibit 99.4 and incorporated by reference herein). The Merger Agreement provides for the merger of AcquireCo with and into Auxilium, with Auxilium surviving the Merger as a wholly owned indirect subsidiary of QLT, on the terms and subject to the conditions set forth in the Merger Agreement. Upon consummation of the Merger, the shares of Auxilium’s common stock will be converted into Shares based on the Equity Exchange Ratio (as defined in the Merger Agreement).
Consummation of the Merger is subject to certain conditions, including receipt of regulatory approvals in the U.S. and Canada, if necessary, the approval of Auxilium’s and QLT’s shareholders, consents under Auxilium’s senior secured credit facility required as a result of the Merger or, in lieu of such consents, the refinancing of such facility, receipt of an opinion of counsel to Auxilium that QLT after giving effect to the Merger should not be treated as a U.S. domestic corporation for U.S. federal income tax purposes, provided that such opinion may only take into account the law in effect on the earlier of the date of the Merger and October 31, 2014, and other negotiated closing conditions.
A description of the Merger and the Merger Agreement can be found in Auxilium’s Current Report on Form 8-K filed with the SEC on June 26, 2014, which description is incorporated herein by reference.
Voting Agreements
As an inducement for Auxilium to enter into the Merger Agreement, and in consideration thereof, the Shareholders entered into the Voting Agreements (attached hereto as Exhibits 99.1 – 99.3 and incorporated by reference herein) with Auxilium. Pursuant to the Voting Agreements, each of the Shareholders has agreed, at any meeting of the shareholders of QLT, however called, or at any adjournment or postponement thereof, or in connection with any written consent of the shareholders of QLT or in any other circumstances upon which a vote, consent or other approval of all or some of the shareholders of QLT is sought, to vote (or cause to be voted) all of such Shareholder’s Owned Securities: (a) in favor of the approval of the Transaction, including without limitation in favor of approval of the QLT Shareholder Resolution (as defined in the Merger Agreement), and any actions required in furtherance thereof; and (b) against the following actions (other than the issuance of Shares in connection with the Merger): (i) any acquisition proposal or merger, takeover bid, amalgamation, plan of arrangement, business combination or similar transaction involving QLT, other than the Transaction (an “Alternative Transaction”); (ii) any reorganization, recapitalization, dissolution, liquidation or winding up of QLT or any of its subsidiaries; (iii) any amendment of QLT’s notice of articles or articles that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction; (iv) any action or transaction that would result in a breach of any representation, warranty, covenant or agreement of QLT under the Merger Agreement; or (v) any other action or transaction that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction.
Each Shareholder also agreed, among other things, subject to certain exceptions, not to (i) directly or indirectly, sell, transfer, tender, pledge, hedge, encumber, gift, assign or otherwise dispose or exchange any of its Owned Securities or enter into any contract, option, agreement, arrangement or understanding (including any profit sharing agreement) in connection therewith (whether by actual disposition, derivative transaction or effective economic disposition through cash settlement); (ii) grant any proxies or powers of attorney, or any other authorization or consent with respect to any or all of such Shareholder’s Owned
Securities or (iii) deposit any of such Shareholder’s Owned Securities into a voting trust or enter into a voting agreement with respect to any of such Shareholder’s Owned Securities; provided that, the Shareholder may transfer Shares to another Shareholder or to a corporation or other entity wholly owned or controlled by a Shareholder or an Affiliate of a Shareholder, provided that (1) such transfer shall not relieve or release the Shareholder of or from its obligations under such Voting Agreement, including, without limitation the obligation of the Shareholder to vote or cause to be voted all its Owned Securities in favor of the Transaction, (2) prompt written notice of such transfer is provided to Auxilium, (3) the transferee agrees to be bound by the terms of the Voting Agreement pursuant to documentation approved in writing by Auxilium in advance of such transfer and (4) the transferee continues to be a QLT Shareholder or a corporation or other entity wholly owned or controlled by a Shareholder or an Affiliate of a QLT Shareholder, at all times prior to the Merger Effective Time (as defined in the Merger Agreement).
The Voting Agreements and the limited proxies granted thereunder terminate and none of Auxilium or any Shareholder shall have any rights or obligations under each Voting Agreement upon the earlier of (i) the consummation of the Transaction or (ii) the termination of the Merger Agreement. Each Voting Agreement may be terminated by Auxilium or the Shareholder (a) at any time prior to the Merger Effective Time, by the mutual agreement of the parties; (b) by the Shareholder, if the Merger Effective Time has not occurred by December 31, 2014 or (c) by the Shareholder, if the Merger Agreement is amended by the parties thereto in a manner that results in an increase in the Equity Exchange Ratio (as defined in the Merger Agreement).
The cover page of this Schedule 13D refers to 16,434,436 Shares beneficially owned by Auxilium with shared voting power and shared dispositive power, representing approximately 32.2% of the total outstanding Shares based on 51,081,878 Shares reported outstanding as of June 25, 2014 (as represented by QLT in the Merger Agreement). However, such percentage and number of Shares may change at or prior to the time of the applicable vote.
The references to, and descriptions of, the Merger Agreement and the Voting Agreements are not intended to be complete and are qualified in their entirety by reference to the Merger Agreement and the Voting Agreements, copies of which are filed as Exhibits hereto and which are incorporated herein by reference.
Except as set forth in this Statement, the Voting Agreements or the Merger Agreement, neither Auxilium nor, to the knowledge of Auxilium, any of the persons listed on Schedule A hereto, has any present plans or proposals which relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.
Item 5. Interest in Securities of the Issuer
(a) Under the definition of “beneficial ownership” as set forth in Rule 13d-3 under the Securities Exchange Act of 1934, as a result of entering into the Voting Agreements, Auxilium may be deemed to have beneficial ownership of 16,434,436 Shares, constituting approximately 32.2% of the 51,081,878 Shares outstanding as of June 25, 2014 (as represented by QLT in the Merger Agreement). Neither the filing of this Statement nor any of its contents shall be deemed to constitute an admission by Auxilium that it is the beneficial owner of any of the Shares referred to herein for purposes of the Act, or for any other purpose, and such beneficial ownership is expressly disclaimed. To Auxilium’s knowledge, no Shares are beneficially owned by any of the persons listed on Schedule A.
(b) As a result of entering into the Voting Agreements, Auxilium may be deemed to have shared power to vote 16,434,436 Shares held by the Shareholders.
(c) Except for the Voting Agreements, the Merger Agreement, and the transactions contemplated by those agreements, neither Auxilium nor, to Auxilium’s knowledge, any person named on Schedule A has effected any transaction in the Shares during the past 60 days.
(d) To Auxilium’s knowledge, no person has the right to receive or power to direct the receipt of
dividends from, or the proceeds from the sale of, the Shares, other than the Shareholder.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
Other than as described in Items 3, 4 and 5, which descriptions are incorporated herein by reference in response to this Item 6, to Auxilium’s knowledge, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among any of the persons named in Item 2 and between such persons and any person with respect to any securities of QLT, including but not limited to the transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.
Item 7. Material to be Filed as Exhibits.
|
Exhibit |
|
Description of Exhibits |
|
99.1 |
|
Voting Agreement, dated as of June 25, 2014, between Auxilium and Axial Capital Management, LLC. |
|
|
|
|
|
99.2 |
|
Voting Agreement, dated as of June 25, 2014, between Auxilium and Kingstown Capital Partners, LLC. |
|
|
|
|
|
99.3 |
|
Voting Agreement, dated as of June 25, 2014, between Auxilium and Visium Balanced Master Fund, Ltd. |
|
|
|
|
|
99.4 |
|
Agreement and Plan of Merger, dated as of June 25, 2014, among Auxilium, QLT, HoldCo and AcquireCo (incorporated by reference to Exhibit 2.1 to Auxilium’s Current Report on Form 8-K, filed on June 26, 2014). |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.
|
Date: July 7, 2014 |
AUXILIUM PHARMACEUTICALS, INC. | |
|
|
| |
|
|
|
|
|
|
By: |
/s/ Andrew I. Koven |
|
|
Name: |
Andrew I. Koven |
|
|
Title: |
Chief Administrative Officer & General Counsel |
SCHEDULE A
Directors and Executive Officers of Auxilium Pharmaceuticals, Inc.
The following table sets forth the name and present principal occupation or employment, and country of citizenship of each of the directors and executive officers of Auxilium. All directors and executive officers listed below are citizens of the United States. The present business address for each director and officer is c/o Auxilium Pharmaceuticals, Inc., 640 Lee Road, Chesterbrook, PA 19087.
Board of Directors
|
Name |
|
Present Principal Occupation or |
|
Citizenship |
|
Rolf A. Classon |
|
Chairman of the Board of Directors of Hill-Rom Corporation, Chairman of the Board of Directors of Tecan Group Ltd., Director of Fresenius Medical Care |
|
Sweden |
|
Adrian Adams |
|
Chief Executive Officer, President and Director of Auxilium, Chairman of the Board of Directors of AcelRX Pharmaceuticals, Inc. |
|
United States |
|
Peter Brandt |
|
Director of Rexahn Pharmaceuticals, Inc. |
|
United States |
|
Oliver S. Fetzer, Ph.D. |
|
President, Chief Executive Officer and Director of Cerulean Pharma Inc., and Director of Tecan Group Ltd. |
|
United States |
|
Paul A. Friedman, M.D. |
|
Director of Gliknik, Inc., Durata Therapeutics, Inc. and Incyte Corporation. |
|
United States |
|
Nancy S. Lurker |
|
Chief Executive Officer and Director of PDI, Inc., and Director of Mallinckrodt plc. |
|
United States |
|
William T. McKee |
|
Director of Cerulean Pharma, Inc. and Agile Therapeutics, Inc.., owner of MBLC Associates, LLC |
|
United States |
|
Executive Officers |
|
|
|
|
|
Adrian Adams |
|
Chief Executive Officer, President and Director |
|
United States |
|
James E. Fickenscher |
|
Chief Financial Officer |
|
United States |
|
Andrew I. Koven |
|
Executive Vice President, Chief Administrative Officer, General Counsel and Secretary |
|
United States |
|
Benjamin J. Del Tito, Jr., Ph.D. |
|
Executive Vice President, Regulatory Affairs and Project Management |
|
United States |
|
Alan J. Wills |
|
Executive Vice President, Corporate Development |
|
United States |
|
Mark A. Glickman |
|
Executive Vice President, Sales and Marketing |
|
United States |
|
James P. Tursi, M.D. |
|
Chief Medical Officer |
|
United States |
|
Jennifer L. Armstrong |
|
Senior Vice President, Human Resources |
|
United States |
|
Elizabeth V. Jobes |
|
Senior Vice President, Chief Compliance Officer |
|
United States |
INDEX TO EXHIBITS
|
Exhibit |
|
Description of Exhibits |
|
99.1 |
|
Voting Agreement, dated as of June 25, 2014, between Auxilium and Axial Capital Management, LLC. |
|
|
|
|
|
99.2 |
|
Voting Agreement, dated as of June 25, 2014, between Auxilium and Kingstown Capital Partners, LLC. |
|
|
|
|
|
99.3 |
|
Voting Agreement, dated as of June 25, 2014, between Auxilium and Visium Balanced Master Fund, Ltd. |
|
|
|
|
|
99.4 |
|
Agreement and Plan of Merger, dated as of June 25, 2014, among Auxilium, QLT, HoldCo and AcquireCo (incorporated by reference to Exhibit 2.1 to Auxilium’s Current Report on Form 8-K, filed on June 26, 2014). |
Exhibit 99.1
VOTING AGREEMENT
THIS AGREEMENT is dated as of June 25, 2014 (this “Agreement”)
BETWEEN:
THE PERSONS NAMED ON THE SIGNATURE PAGE HERETO
(each such person a “Company Shareholder”)
AND:
Auxilium Pharmaceuticals, Inc., a corporation incorporated under the laws of Delaware
(“Auxilium”).
WHEREAS:
A. QLT Inc., a corporation incorporated under the laws of British Columbia (the “Company”), Auxilium, QLT Holding Corp., a corporation incorporated under the laws of Delaware and a wholly-owned subsidiary of the Company (“Holdco”) and QLT Acquisition Corp., a corporation incorporated under the laws of Delaware (“AcquireCo”), have entered into an Agreement and Plan of Merger (the “Merger Agreement”) providing for the merger of AcquireCo with and into Auxilium, with Auxilium being the surviving corporation, pursuant to which the shares of Auxilium will be converted into the right to receive common shares of the Company (such transactions, together with any other transaction contemplated by the Merger Agreement, the “Transaction”);
B. The Company Shareholders or their Affiliates (which includes for the purposes of this Agreement, any entity controlled by a Company Shareholder or an Affiliate of any entity controlled by a Company Shareholder) are the record or beneficial owners (as defined under Rule 13d-3 under the Securities Exchange Act of 1934, as amended) or have voting or dispositive power over the number of common shares without par value of the Company (the “Shares”), set forth next to each Company Shareholder’s name in Schedule A of this Agreement;
C. Auxilium requires the Company Shareholders to enter into this Agreement with respect to the Shares in order to set out the terms and conditions of the agreement of the Company Shareholders to support the Transaction and to vote the Shares in favour of the Transaction at any meeting of the Company’s shareholders called to consider such Transaction; and
D. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms by the Merger Agreement.
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the covenants and agreements herein contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
1. Agreement to Vote Securities. At any meeting of the shareholders of the Company, however called, or at any adjournment or postponement thereof, or in connection with
any written consent of the shareholders of the Company or in any other circumstances upon which a vote, consent or other approval of all or some of the shareholders of the Company is sought, each Company Shareholder shall vote (or cause to be voted) all of such Company Shareholder’s Shares and any other shares of capital stock of the Company owned, beneficially or of record as set forth next to its name in Schedule A of this Agreement (with respect to each Company Shareholder, its “Owned Securities”):
(a) in favor of approval of the Transaction, including without limitation in favor of approval of the QLT Shareholder Resolution, and any actions required in furtherance thereof; and
(b) against the following actions (other than the issuance of the Company Shares in connection with the Merger): (i) any acquisition proposal or merger, takeover bid, amalgamation, plan of arrangement, business combination or similar transaction involving the Company, other than the Transaction (an “Alternative Transaction”); (ii) any reorganization, recapitalization, dissolution, liquidation or winding up of the Company or any of its subsidiaries; (iii) any amendment of the Company’s notice of articles or articles that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction; (iv) any action or transaction that would result in a breach of any representation, warranty covenant or agreement of the Company under the Merger Agreement; or (v) any other action or transaction that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction.
2. Representations of the Company Shareholder. Each Company Shareholder, severally and not jointly, represents and warrants to Auxilium (and acknowledges that Auxilium is relying upon such representations and warranties) as follows:
(a) It or one of its Affiliates is the record or beneficial owner of the Owned Securities with good and marketable title thereto free and clear of any liens, pledges, mortgages, charges, restrictions, security interests, adverse claims and demands or rights of others of any nature or kind whatsoever (including without limitation any restriction on the right to vote, tender or otherwise transfer such Owned Securities).
(b) No person has any agreement or option, or any right or privilege, whether by law, pre-emptive or contractual, capable of becoming an agreement or option, for the exchange, acquisition or transfer from the Company Shareholder or any of its Affiliates of any of its Owned Securities or any interest therein or right thereto.
(c) It or one of its Affiliates has sole voting power and exclusive right of disposition with respect to its Owned Securities and sole power to agree to all matters set forth in this Agreement and neither the Company Shareholder nor any of its Affiliates has previously granted or agreed to grant a proxy or other right to vote in respect of such Owned Securities or entered into any voting trust, nor pooling or other agreement with respect to the right to vote, call meetings of
securityholders or give consents or approvals of any kind as to such Owned Securities except those which are no longer of force or effect.
(d) Neither it nor any of its Affiliates beneficially owns or controls any securities of the Company other than its Owned Securities.
(e) It has the legal capacity, power and authority to execute and deliver this Agreement and perform its obligations hereunder. This Agreement has been duly executed and delivered by the Company Shareholder and, assuming the due authorization, execution and delivery by Auxilium, this Agreement constitutes the legal, valid and binding obligation of the Company Shareholder, enforceable in accordance with its terms, subject to laws of general application and bankruptcy, insolvency and other similar laws affecting creditors’ rights generally and general principles of equity.
(f) Except as may be set forth in the Merger Agreement or as otherwise required by law (including, without limitation, filings as may be required under applicable securities laws), no filing with, and no permit, authorization, consent, or approval of, any Governmental Authority is necessary for the execution of this Agreement by the Company Shareholder and the performance by the Company Shareholder of its obligations under this Agreement, and (ii) none of the execution and delivery of this Agreement by the Company Shareholder, the performance by the Company Shareholder of its obligations under this Agreement or compliance by the Company Shareholder with any of the provisions of this Agreement shall (A) conflict with or result in any breach of the organizational documents, if applicable, of the Company Shareholder, (B) result in a material violation or material breach of, or constitute (with or without notice or lapse of time, or both) a default (or give rise to any third party right of termination, cancellation, amendment, or acceleration) under any of the terms, conditions, or provisions of any material note, bond, mortgage, indenture, license, contract, commitment, arrangement, understanding, agreement, or other instrument or obligation of any kind to which the Company Shareholder is a party, or (C) violate any order, writ, injunction, decree, judgment, statute, rule, or regulation applicable to the Company Shareholder, except in each case under clauses (B) and (C), where the absence of filing or authorization, conflict, violation, breach, or default would not materially impair or materially adversely affect the ability of such Company Shareholder to perform such Company Shareholder’s obligations hereunder on a timely basis.
(g) To the knowledge of the Company Shareholder, there is no private or governmental action, suit, proceeding, claim, arbitration or investigation pending before any Governmental Authority, or threatened against the Company Shareholder, any of its Affiliates or any of their respective properties that, individually or in the aggregate, could reasonably be expected to have a material adverse effect on the Company Shareholder’s ability to perform its obligations under this Agreement. To the knowledge of the Company Shareholder, there is no judgment, decree or order against the Company Shareholder or any of its
Affiliates that could prevent, enjoin, alter or materially delay any of the transactions contemplated by this Agreement, or that could reasonably be expected to have a material adverse effect on the Company Shareholder’s ability to perform its obligations under this Agreement.
3. Representations of Auxilium. Auxilium represents and warrants to the Company Shareholders that (and acknowledges that the Company Shareholders are relying upon such representations and warranties):
(a) Auxilium is, and will be as at the Effective Time, validly existing under the laws of Delaware;
(b) it has the requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder;
(c) it has full power and authority to make, enter into and carry out the terms of this Agreement;
(d) no consent, approval or authorization of, or declaration or filing with, or notice to, any governmental entity or stock exchange which has not been received or made is required by Auxilium in connection with the execution and delivery of this Agreement;
(e) there are no legal proceedings in progress or pending before any governmental entity, or to the knowledge of Auxilium, threatened against Auxilium or its Affiliates that would adversely affect in any manner the ability of Auxilium to enter into this Agreement or the Merger Agreement and to perform its obligations hereunder or thereunder.
4. No Action to Reduce Likelihood of Success or Delay. Each Company Shareholder will not, and will not permit any of its Affiliates to:
(a) solicit proxies or become a participant in a solicitation of proxies for any Alternative Transaction;
(b) assist any person, entity or group in taking or planning any action that would compete with, restrain or otherwise serve to interfere with or inhibit Auxilium in connection with the Transaction;
(c) solicit, initiate, knowingly encourage or knowingly facilitate a stockholders’ vote with respect to any Alternative Transaction;
(d) become a member of a “group” (as defined by the Securities Exchange Act of 1934, as amended) or act jointly or in concert (as “acting jointly or in concert” is interpreted under applicable Canadian securities Laws) with respect to any voting securities of the Company with respect to any Alternative Transaction;
(e) take any other action of any kind that might reasonably be regarded as likely to reduce the success of, or delay or interfere or compete with the completion of, the proposed Transaction or any other transaction contemplated by the Merger Agreement;
(f) solicit, initiate, encourage or facilitate any QLT Acquisition Proposal;
(g) participate in any discussions, conversations, negotiations or other communications with any person with respect to a QLT Acquisition Proposal; or
(h) furnish any information to any person in connection with a proposed QLT Acquisition Proposal or otherwise assist, facilitate or encourage the making of, or cooperate in any way regarding, any QLT Acquisition Proposal.
5. Covenants of Company Shareholders. Except with the prior written consent of Auxilium, each Company Shareholder and/or any of its Affiliates agrees as follows:
(a) No later than one (1) Business Day before the date of any meeting of the shareholders of the Company, each Company Shareholder shall deliver or cause to be delivered to the Company, with a copy to Auxilium concurrently, a duly executed proxy or proxies in respect of the Owned Securities directing those individuals as may be designated by the Company in the Joint Proxy Statement/Circular to vote the Owned Securities in accordance with paragraph 1, and each such proxy or proxies shall not be revoked without the written consent of Auxilium.
(b) Each Company Shareholder shall not (i) directly or indirectly, sell, transfer, tender, pledge, hedge, encumber, gift, assign or otherwise dispose of or exchange any or all of its Owned Securities or enter into any contract, option, agreement, arrangement or understanding (including any profit sharing agreement) in connection therewith (whether by actual disposition, derivative transaction or effective economic disposition through cash settlement), (ii) grant any proxies or powers of attorney, or any other authorization or consent with respect to any or all of such Company Shareholder’s Owned Securities or (iii) deposit any of such Company Shareholder’s Owned Securities into a voting trust or enter into a voting agreement with respect to any of such Company Shareholder’s Owned Securities; provided that, the Company Shareholder may transfer Shares to another Company Shareholder or to a corporation or other entity wholly owned or controlled by a Company Shareholder or an Affiliate of a Company Shareholder, provided that (1) such transfer shall not relieve or release the Company Shareholder of or from its obligations under this Agreement, including, without limitation the obligation of the Company Shareholder to vote or cause to be voted all its Owned Securities in favour of the Transaction, (2) prompt written notice of such transfer is provided to Auxilium, (3) the transferee agrees to be bound by the terms hereof pursuant to documentation approved in writing by Auxilium in advance of such transfer and (4) the transferee continues to be a Company Shareholder or a corporation or
other entity wholly owned or controlled by a Company Shareholder or an Affiliate of a Company Shareholder, at all times prior to the Effective Time.
(c) Each Company Shareholder agrees with, and covenants to, Auxilium that (i) this Agreement and the obligations hereunder shall attach to the Company Shareholder’s Owned Securities and shall be binding upon any person or entity to which legal or beneficial ownership shall pass, whether by operation of law or otherwise, including, without limitation, such Company Shareholder’s successors or assigns and (ii) the Company Shareholder shall not request that the Company register the transfer (book-entry or otherwise) of any certificate or uncertificated interest representing any or all of the Company Shareholder’s Owned Securities, unless such transfer is made in compliance with this Agreement and such Company Shareholder shall promptly following the date hereof authorize and instruct the Company to instruct its transfer agent to enter a stop transfer order with respect to all of its Owned Securities with respect to any transfer not permitted hereunder.
(d) Each Company Shareholder hereby covenants and agrees that it will not exercise any rights of appraisal or rights of dissent provided under any applicable laws or otherwise in connection with the Transaction at any shareholder meeting in connection therewith.
(e) Each Company Shareholder hereby agrees not to commence or join in, and agrees to take all actions necessary to opt out of any class, in any proceeding asserting a claim, derivative or otherwise, against Auxilium, Holdco, AcquireCo, or the Company or any of their respective successors or Affiliates (x) challenging the validity of, or seeking to enjoin in whole or in part the operation of this Agreement or the Merger Agreement or (y) alleging oppression or a breach of any fiduciary duty of any person in connection with the negotiation and entry into the Merger Agreement.
(f) In the event any Company Shareholder becomes the record or beneficial owner of (i) any common shares of the Company or any other securities of the Company, (ii) any securities which may be converted into or exchanged for such shares or other securities or (iii) any securities issued in replacement of, or as a dividend or distribution on, or otherwise in respect of, such shares or other securities (collectively, “Additional Securities”), the terms of this Agreement shall apply to any of such Additional Securities as though owned by such Company Shareholder on the date of this Agreement.
(g) Each Company Shareholder is entering into this Agreement solely in its capacity as the record or beneficial owner of its Owned Securities. Nothing contained in this Agreement shall limit the rights and obligations of any Company Shareholder, any of its Affiliates, representatives or any employee of any of its Affiliates in his or her capacity as a director or officer of the Company, and the agreements set forth herein shall in no way restrict any director or officer of the Company in the exercise of his or her fiduciary duties as a director or officer of
the Company in his or her capacity as such. Each Company Shareholder shall have no liability to Auxilium or any of its Affiliates under this Agreement as a result of any action or inaction by such Company Shareholder acting in his capacity as a director or officer of the Company.
6. Other Covenants. The Company Shareholder also agrees, severally and not jointly to the details of this Agreement being set out in any information circular or disclosure document produced by the Company or Auxilium in connection with the Transaction and to this Agreement being available for public inspection to the extent required by law.
7. Auxilium Acknowledgements. Auxilium acknowledges that, if any Company Shareholder is also a director, officer or employee of the Company or any of its subsidiaries, that the provisions of this Agreement shall bind such Company Shareholder solely in his or her capacity as a shareholder of the Company and shall not be deemed or interpreted to bind any such Company Shareholder in his or her capacity as a director, officer or employee of the Company or any of its subsidiaries.
8. Termination. Unless otherwise provided for herein, this Agreement shall terminate on the earlier of: (i) the consummation of the Transaction and (ii) termination of the Merger Agreement.
9. Termination by the Company Shareholder or Auxilium. This Agreement may be terminated by notice in writing:
(a) at any time prior to the Effective Time, by the mutual agreement of the parties;
(b) by the Company Shareholder, if the Merger Effective Time has not occurred by December 31, 2014; or
(c) by the Company Shareholder, if the Merger Agreement is amended by the parties thereto in a manner that results in an increase in the Equity Exchange Ratio.
10. Specific Performance. The parties agree that irreparable harm would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached for which money damages would not be an adequate remedy at Law. It is accordingly agreed that the parties hereto will be entitled to an injunction or injunctions and other equitable relief to prevent breaches of this Agreement, any requirement for the securing or posting of any bond in connection with the obtaining of any such injunctive or other equitable relief hereby being waived.
11. No Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Auxilium any direct or indirect ownership or incidence of ownership at law or in equity with respect to any of the Owned Securities or any right or entitlement to acquire or become the owner at law or in equity of the Owned Securities. Except as otherwise set forth in this Agreement, any rights, ownership and economic benefits of and relating to the Owned Securities shall remain vested in and belong to the Company Shareholders and their Affiliates, as the case may be. Auxilium shall have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or
operations of the Company or exercise any power or authority to direct any Company Shareholder or his or her Affiliates in the voting of any of the Owned Securities, except as otherwise provided herein, or in the performance of the Company Shareholder’s and its Affiliates’ duties or responsibilities as a Company Shareholder of the Company.
12. Successors and Assigns. The provisions of this Agreement shall be binding upon and enure to the benefit of the parties hereto and their respective successors and permitted assigns, provided that no party may assign, delegate or otherwise transfer any of its or his rights, interests or obligations under this Agreement without the prior written consent of the other party, except that Auxilium may assign, delegate or otherwise transfer any of its rights, interests or obligations under this Agreement to a direct or indirect subsidiary, without reducing its own obligations hereunder, without the prior consent of the Company Shareholders.
13. Confidentiality. Each Company Shareholder shall maintain in confidence the matters referred to in this Agreement and shall not make any public disclosure, except to the extent required by applicable law or the requirements of any securities regulatory authority or stock exchange, of the terms of this Agreement without the consent of Auxilium, such consent not to be unreasonably withheld.
14. Entire Agreement. This Agreement supersedes all prior agreements among the parties hereto with respect to the subject matter hereof and contains the entire agreement among the parties with respect to the subject matter hereof. This Agreement may not be modified or waived, except expressly by an instrument in writing signed by all the parties hereto. No waiver of any provision hereof by any party shall be deemed a waiver by any other party nor shall any such waiver be deemed a continuing waiver of any matter by such party.
15. Notice. Any demand, notice or other communication to be given in connection with this Agreement must be given in writing and will be given by personal delivery or by electronic means of communication addressed to the recipient as follows:
|
if to any Company Shareholder: |
|
The addresses set out on the last page of this Agreement |
|
|
|
|
|
if to Auxilium: |
|
The addresses set out for Auxilium in the Merger Agreement |
Any demand, notice or other communication given by personal delivery will be conclusively deemed to have been given on the day of actual delivery thereof and, if given by electronic communication, on the day of transmittal thereof if given during the normal business hours of the recipient and on the business day during which such normal business hours next occur if not given during such hours on any day.
16. Further Assurances. Each of the parties hereto agrees to execute such further and other deeds, documents and assurances and to do such further and other acts as may be necessary to carry out the true intent and meaning of this Agreement fully and effectually.
17. Severability. Each of the covenants, provisions, sections, subsections and other subdivisions hereof is severable from every other covenant, provision, section, subsection and subdivision and the invalidity or unenforceability of any one or more covenants, provisions, sections, subsections and other subdivisions hereof shall not affect the validity or enforceability of the remaining covenants, provisions, sections, subsections or subdivisions hereof.
18. Governing Law. This Agreement, and any dispute arising out of, relating to, or in connection with this Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware of any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. Each of the parties (a) consents to submit itself to the personal jurisdiction of the Court of Chancery of the State of Delaware (the “Chancery Court”) or, if, but only if, the Chancery Court lacks subject matter jurisdiction, any Federal court located in the State of Delaware with respect to any dispute arising out of, relating to or in connection with this Agreement or any transaction contemplated hereby, (b) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court and (c) agrees that it will not bring any action arising out of, relating to or in connection with this Agreement or any transaction contemplated by this Agreement, in any court other than any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or the transactions contemplated hereby in the Chancery Court or, if, but only if, the Chancery Court lacks subject matter jurisdiction, in any Federal court located in the State of Delaware, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
19. Counterparts. This Agreement may be executed and delivered in any number of counterparts (including by facsimile or electronic transmission), each of which will be deemed to be an original and all of which taken together will be deemed to constitute one and the same instrument, and each party may enter into this Agreement by executing a counterpart and delivering it to the other party (by personal delivery, facsimile, electronic transmission or otherwise).
20. Interpretation Not Affected by Headings. The division of this Agreement into articles, sections, paragraphs and subparagraphs and the insertion of a table of contents and headings are for convenience of reference only and do not affect the construction or interpretation of this Agreement. The terms “this Agreement”, “hereof”, “herein”, “hereunder” and similar expressions refer to this Agreement, and not to any particular article, section or other portion hereof. Unless something in the subject matter or context is clearly inconsistent therewith, references herein to an article, section, subsection,
paragraph, clause, subclause or schedule by number or letter or both are to that article, section, subsection, paragraph, clause or subclause in this Agreement.
IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first above written.
|
AUXILIUM PHARMACEUTICALS, INC. |
| |
|
|
| |
|
/s/ Adrian Adams |
| |
|
|
| |
|
Name: |
Adrian Adams |
|
|
|
|
|
|
Title: |
Chief Executive Officer and President |
|
|
|
| |
|
|
| |
|
COMPANY SHAREHOLDER: |
| |
|
|
| |
|
AXIAL CAPITAL MANAGEMENT, LLC |
| |
|
|
| |
|
/s/ Eliav Assouline |
| |
|
|
| |
|
Name: |
Eliav Assouline |
|
|
|
|
|
|
Title: |
Managing Member |
|
|
|
|
|
|
|
|
|
|
Address: |
101 Park Avenue |
|
|
|
|
|
|
|
New York, NY 10178 |
|
Exhibit 99.2
VOTING AGREEMENT
THIS AGREEMENT is dated as of June 25, 2014 (this “Agreement”)
BETWEEN:
THE PERSONS NAMED ON THE SIGNATURE PAGE HERETO
(each such person a “Company Shareholder”)
AND:
Auxilium Pharmaceuticals, Inc., a corporation incorporated under the laws of Delaware
(“Auxilium”).
WHEREAS:
A. QLT Inc., a corporation incorporated under the laws of British Columbia (the “Company”), Auxilium, QLT Holding Corp., a corporation incorporated under the laws of Delaware and a wholly-owned subsidiary of the Company (“Holdco”) and QLT Acquisition Corp., a corporation incorporated under the laws of Delaware (“AcquireCo”), have entered into an Agreement and Plan of Merger (the “Merger Agreement”) providing for the merger of AcquireCo with and into Auxilium, with Auxilium being the surviving corporation, pursuant to which the shares of Auxilium will be converted into the right to receive common shares of the Company (such transactions, together with any other transaction contemplated by the Merger Agreement, the “Transaction”);
B. The Company Shareholders or their Affiliates (which includes for the purposes of this Agreement, any entity controlled by a Company Shareholder or an Affiliate of any entity controlled by a Company Shareholder) are the record or beneficial owners (as defined under Rule 13d-3 under the Securities Exchange Act of 1934, as amended) or have voting or dispositive power over the number of common shares without par value of the Company (the “Shares”), set forth next to each Company Shareholder’s name in Schedule A of this Agreement;
C. Auxilium requires the Company Shareholders to enter into this Agreement with respect to the Shares in order to set out the terms and conditions of the agreement of the Company Shareholders to support the Transaction and to vote the Shares in favour of the Transaction at any meeting of the Company’s shareholders called to consider such Transaction; and
D. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms by the Merger Agreement.
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the covenants and agreements herein contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
1. Agreement to Vote Securities. At any meeting of the shareholders of the Company, however called, or at any adjournment or postponement thereof, or in connection with
any written consent of the shareholders of the Company or in any other circumstances upon which a vote, consent or other approval of all or some of the shareholders of the Company is sought, each Company Shareholder shall vote (or cause to be voted) all of such Company Shareholder’s Shares and any other shares of capital stock of the Company owned, beneficially or of record as set forth next to its name in Schedule A of this Agreement (with respect to each Company Shareholder, its “Owned Securities”):
(a) in favor of approval of the Transaction, including without limitation in favor of approval of the QLT Shareholder Resolution, and any actions required in furtherance thereof; and
(b) against the following actions (other than the issuance of the Company Shares in connection with the Merger): (i) any acquisition proposal or merger, takeover bid, amalgamation, plan of arrangement, business combination or similar transaction involving the Company, other than the Transaction (an “Alternative Transaction”); (ii) any reorganization, recapitalization, dissolution, liquidation or winding up of the Company or any of its subsidiaries; (iii) any amendment of the Company’s notice of articles or articles that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction; (iv) any action or transaction that would result in a breach of any representation, warranty covenant or agreement of the Company under the Merger Agreement; or (v) any other action or transaction that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction.
2. Representations of the Company Shareholder. Each Company Shareholder, severally and not jointly, represents and warrants to Auxilium (and acknowledges that Auxilium is relying upon such representations and warranties) as follows:
(a) It or one of its Affiliates is the record or beneficial owner of the Owned Securities with good and marketable title thereto free and clear of any liens, pledges, mortgages, charges, restrictions, security interests, adverse claims and demands or rights of others of any nature or kind whatsoever (including without limitation any restriction on the right to vote, tender or otherwise transfer such Owned Securities).
(b) No person has any agreement or option, or any right or privilege, whether by law, pre-emptive or contractual, capable of becoming an agreement or option, for the exchange, acquisition or transfer from the Company Shareholder or any of its Affiliates of any of its Owned Securities or any interest therein or right thereto.
(c) It or one of its Affiliates has sole voting power and exclusive right of disposition with respect to its Owned Securities and sole power to agree to all matters set forth in this Agreement and neither the Company Shareholder nor any of its Affiliates has previously granted or agreed to grant a proxy or other right to vote in respect of such Owned Securities or entered into any voting trust, nor pooling or other agreement with respect to the right to vote, call meetings of
securityholders or give consents or approvals of any kind as to such Owned Securities except those which are no longer of force or effect.
(d) Neither it nor any of its Affiliates beneficially owns or controls any securities of the Company other than its Owned Securities.
(e) It has the legal capacity, power and authority to execute and deliver this Agreement and perform its obligations hereunder. This Agreement has been duly executed and delivered by the Company Shareholder and, assuming the due authorization, execution and delivery by Auxilium, this Agreement constitutes the legal, valid and binding obligation of the Company Shareholder, enforceable in accordance with its terms, subject to laws of general application and bankruptcy, insolvency and other similar laws affecting creditors’ rights generally and general principles of equity.
(f) Except as may be set forth in the Merger Agreement or as otherwise required by law (including, without limitation, filings as may be required under applicable securities laws), no filing with, and no permit, authorization, consent, or approval of, any Governmental Authority is necessary for the execution of this Agreement by the Company Shareholder and the performance by the Company Shareholder of its obligations under this Agreement, and (ii) none of the execution and delivery of this Agreement by the Company Shareholder, the performance by the Company Shareholder of its obligations under this Agreement or compliance by the Company Shareholder with any of the provisions of this Agreement shall (A) conflict with or result in any breach of the organizational documents, if applicable, of the Company Shareholder, (B) result in a material violation or material breach of, or constitute (with or without notice or lapse of time, or both) a default (or give rise to any third party right of termination, cancellation, amendment, or acceleration) under any of the terms, conditions, or provisions of any material note, bond, mortgage, indenture, license, contract, commitment, arrangement, understanding, agreement, or other instrument or obligation of any kind to which the Company Shareholder is a party, or (C) violate any order, writ, injunction, decree, judgment, statute, rule, or regulation applicable to the Company Shareholder, except in each case under clauses (B) and (C), where the absence of filing or authorization, conflict, violation, breach, or default would not materially impair or materially adversely affect the ability of such Company Shareholder to perform such Company Shareholder’s obligations hereunder on a timely basis.
(g) To the knowledge of the Company Shareholder, there is no private or governmental action, suit, proceeding, claim, arbitration or investigation pending before any Governmental Authority, or threatened against the Company Shareholder, any of its Affiliates or any of their respective properties that, individually or in the aggregate, could reasonably be expected to have a material adverse effect on the Company Shareholder’s ability to perform its obligations under this Agreement. To the knowledge of the Company Shareholder, there is no judgment, decree or order against the Company Shareholder or any of its
Affiliates that could prevent, enjoin, alter or materially delay any of the transactions contemplated by this Agreement, or that could reasonably be expected to have a material adverse effect on the Company Shareholder’s ability to perform its obligations under this Agreement.
3. Representations of Auxilium. Auxilium represents and warrants to the Company Shareholders that (and acknowledges that the Company Shareholders are relying upon such representations and warranties):
(a) Auxilium is, and will be as at the Effective Time, validly existing under the laws of Delaware;
(b) it has the requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder;
(c) it has full power and authority to make, enter into and carry out the terms of this Agreement;
(d) no consent, approval or authorization of, or declaration or filing with, or notice to, any governmental entity or stock exchange which has not been received or made is required by Auxilium in connection with the execution and delivery of this Agreement;
(e) there are no legal proceedings in progress or pending before any governmental entity, or to the knowledge of Auxilium, threatened against Auxilium or its Affiliates that would adversely affect in any manner the ability of Auxilium to enter into this Agreement or the Merger Agreement and to perform its obligations hereunder or thereunder.
4. No Action to Reduce Likelihood of Success or Delay. Each Company Shareholder will not, and will not permit any of its Affiliates to:
(a) solicit proxies or become a participant in a solicitation of proxies for any Alternative Transaction;
(b) assist any person, entity or group in taking or planning any action that would compete with, restrain or otherwise serve to interfere with or inhibit Auxilium in connection with the Transaction;
(c) solicit, initiate, knowingly encourage or knowingly facilitate a stockholders’ vote with respect to any Alternative Transaction;
(d) become a member of a “group” (as defined by the Securities Exchange Act of 1934, as amended) or act jointly or in concert (as “acting jointly or in concert” is interpreted under applicable Canadian securities Laws) with respect to any voting securities of the Company with respect to any Alternative Transaction;
(e) take any other action of any kind that might reasonably be regarded as likely to reduce the success of, or delay or interfere or compete with the completion of, the proposed Transaction or any other transaction contemplated by the Merger Agreement;
(f) solicit, initiate, encourage or facilitate any QLT Acquisition Proposal;
(g) participate in any discussions, conversations, negotiations or other communications with any person with respect to a QLT Acquisition Proposal; or
(h) furnish any information to any person in connection with a proposed QLT Acquisition Proposal or otherwise assist, facilitate or encourage the making of, or cooperate in any way regarding, any QLT Acquisition Proposal.
5. Covenants of Company Shareholders. Except with the prior written consent of Auxilium, each Company Shareholder and/or any of its Affiliates agrees as follows:
(a) No later than one (1) Business Day before the date of any meeting of the shareholders of the Company, each Company Shareholder shall deliver or cause to be delivered to the Company, with a copy to Auxilium concurrently, a duly executed proxy or proxies in respect of the Owned Securities directing those individuals as may be designated by the Company in the Joint Proxy Statement/Circular to vote the Owned Securities in accordance with paragraph 1, and each such proxy or proxies shall not be revoked without the written consent of Auxilium.
(b) Each Company Shareholder shall not (i) directly or indirectly, sell, transfer, tender, pledge, hedge, encumber, gift, assign or otherwise dispose of or exchange any or all of its Owned Securities or enter into any contract, option, agreement, arrangement or understanding (including any profit sharing agreement) in connection therewith (whether by actual disposition, derivative transaction or effective economic disposition through cash settlement), (ii) grant any proxies or powers of attorney, or any other authorization or consent with respect to any or all of such Company Shareholder’s Owned Securities or (iii) deposit any of such Company Shareholder’s Owned Securities into a voting trust or enter into a voting agreement with respect to any of such Company Shareholder’s Owned Securities; provided that, the Company Shareholder may transfer Shares to another Company Shareholder or to a corporation or other entity wholly owned or controlled by a Company Shareholder or an Affiliate of a Company Shareholder, provided that (1) such transfer shall not relieve or release the Company Shareholder of or from its obligations under this Agreement, including, without limitation the obligation of the Company Shareholder to vote or cause to be voted all its Owned Securities in favour of the Transaction, (2) prompt written notice of such transfer is provided to Auxilium, (3) the transferee agrees to be bound by the terms hereof pursuant to documentation approved in writing by Auxilium in advance of such transfer and (4) the transferee continues to be a Company Shareholder or a corporation or
other entity wholly owned or controlled by a Company Shareholder or an Affiliate of a Company Shareholder, at all times prior to the Effective Time.
(c) Each Company Shareholder agrees with, and covenants to, Auxilium that (i) this Agreement and the obligations hereunder shall attach to the Company Shareholder’s Owned Securities and shall be binding upon any person or entity to which legal or beneficial ownership shall pass, whether by operation of law or otherwise, including, without limitation, such Company Shareholder’s successors or assigns and (ii) the Company Shareholder shall not request that the Company register the transfer (book-entry or otherwise) of any certificate or uncertificated interest representing any or all of the Company Shareholder’s Owned Securities, unless such transfer is made in compliance with this Agreement and such Company Shareholder shall promptly following the date hereof authorize and instruct the Company to instruct its transfer agent to enter a stop transfer order with respect to all of its Owned Securities with respect to any transfer not permitted hereunder.
(d) Each Company Shareholder hereby covenants and agrees that it will not exercise any rights of appraisal or rights of dissent provided under any applicable laws or otherwise in connection with the Transaction at any shareholder meeting in connection therewith.
(e) Each Company Shareholder hereby agrees not to commence or join in, and agrees to take all actions necessary to opt out of any class, in any proceeding asserting a claim, derivative or otherwise, against Auxilium, Holdco, AcquireCo, or the Company or any of their respective successors or Affiliates (x) challenging the validity of, or seeking to enjoin in whole or in part the operation of this Agreement or the Merger Agreement or (y) alleging oppression or a breach of any fiduciary duty of any person in connection with the negotiation and entry into the Merger Agreement.
(f) In the event any Company Shareholder becomes the record or beneficial owner of (i) any common shares of the Company or any other securities of the Company, (ii) any securities which may be converted into or exchanged for such shares or other securities or (iii) any securities issued in replacement of, or as a dividend or distribution on, or otherwise in respect of, such shares or other securities (collectively, “Additional Securities”), the terms of this Agreement shall apply to any of such Additional Securities as though owned by such Company Shareholder on the date of this Agreement.
(g) Each Company Shareholder is entering into this Agreement solely in its capacity as the record or beneficial owner of its Owned Securities. Nothing contained in this Agreement shall limit the rights and obligations of any Company Shareholder, any of its Affiliates, representatives or any employee of any of its Affiliates in his or her capacity as a director or officer of the Company, and the agreements set forth herein shall in no way restrict any director or officer of the Company in the exercise of his or her fiduciary duties as a director or officer of
the Company in his or her capacity as such. Each Company Shareholder shall have no liability to Auxilium or any of its Affiliates under this Agreement as a result of any action or inaction by such Company Shareholder acting in his capacity as a director or officer of the Company.
6. Other Covenants. The Company Shareholder also agrees, severally and not jointly to the details of this Agreement being set out in any information circular or disclosure document produced by the Company or Auxilium in connection with the Transaction and to this Agreement being available for public inspection to the extent required by law.
7. Auxilium Acknowledgements. Auxilium acknowledges that, if any Company Shareholder is also a director, officer or employee of the Company or any of its subsidiaries, that the provisions of this Agreement shall bind such Company Shareholder solely in his or her capacity as a shareholder of the Company and shall not be deemed or interpreted to bind any such Company Shareholder in his or her capacity as a director, officer or employee of the Company or any of its subsidiaries.
8. Termination. Unless otherwise provided for herein, this Agreement shall terminate on the earlier of: (i) the consummation of the Transaction and (ii) termination of the Merger Agreement.
9. Termination by the Company Shareholder or Auxilium. This Agreement may be terminated by notice in writing:
(a) at any time prior to the Effective Time, by the mutual agreement of the parties;
(b) by the Company Shareholder, if the Merger Effective Time has not occurred by December 31, 2014; or
(c) by the Company Shareholder, if the Merger Agreement is amended by the parties thereto in a manner that results in an increase in the Equity Exchange Ratio.
10. Specific Performance. The parties agree that irreparable harm would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached for which money damages would not be an adequate remedy at Law. It is accordingly agreed that the parties hereto will be entitled to an injunction or injunctions and other equitable relief to prevent breaches of this Agreement, any requirement for the securing or posting of any bond in connection with the obtaining of any such injunctive or other equitable relief hereby being waived.
11. No Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Auxilium any direct or indirect ownership or incidence of ownership at law or in equity with respect to any of the Owned Securities or any right or entitlement to acquire or become the owner at law or in equity of the Owned Securities. Except as otherwise set forth in this Agreement, any rights, ownership and economic benefits of and relating to the Owned Securities shall remain vested in and belong to the Company Shareholders and their Affiliates, as the case may be. Auxilium shall have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or
operations of the Company or exercise any power or authority to direct any Company Shareholder or his or her Affiliates in the voting of any of the Owned Securities, except as otherwise provided herein, or in the performance of the Company Shareholder’s and its Affiliates’ duties or responsibilities as a Company Shareholder of the Company.
12. Successors and Assigns. The provisions of this Agreement shall be binding upon and enure to the benefit of the parties hereto and their respective successors and permitted assigns, provided that no party may assign, delegate or otherwise transfer any of its or his rights, interests or obligations under this Agreement without the prior written consent of the other party, except that Auxilium may assign, delegate or otherwise transfer any of its rights, interests or obligations under this Agreement to a direct or indirect subsidiary, without reducing its own obligations hereunder, without the prior consent of the Company Shareholders.
13. Confidentiality. Each Company Shareholder shall maintain in confidence the matters referred to in this Agreement and shall not make any public disclosure, except to the extent required by applicable law or the requirements of any securities regulatory authority or stock exchange, of the terms of this Agreement without the consent of Auxilium, such consent not to be unreasonably withheld.
14. Entire Agreement. This Agreement supersedes all prior agreements among the parties hereto with respect to the subject matter hereof and contains the entire agreement among the parties with respect to the subject matter hereof. This Agreement may not be modified or waived, except expressly by an instrument in writing signed by all the parties hereto. No waiver of any provision hereof by any party shall be deemed a waiver by any other party nor shall any such waiver be deemed a continuing waiver of any matter by such party.
15. Notice. Any demand, notice or other communication to be given in connection with this Agreement must be given in writing and will be given by personal delivery or by electronic means of communication addressed to the recipient as follows:
|
if to any Company Shareholder: |
|
The addresses set out on the last page of this Agreement |
|
|
|
|
|
if to Auxilium: |
|
The addresses set out for Auxilium in the Merger Agreement |
Any demand, notice or other communication given by personal delivery will be conclusively deemed to have been given on the day of actual delivery thereof and, if given by electronic communication, on the day of transmittal thereof if given during the normal business hours of the recipient and on the business day during which such normal business hours next occur if not given during such hours on any day.
16. Further Assurances. Each of the parties hereto agrees to execute such further and other deeds, documents and assurances and to do such further and other acts as may be necessary to carry out the true intent and meaning of this Agreement fully and effectually.
17. Severability. Each of the covenants, provisions, sections, subsections and other subdivisions hereof is severable from every other covenant, provision, section, subsection and subdivision and the invalidity or unenforceability of any one or more covenants, provisions, sections, subsections and other subdivisions hereof shall not affect the validity or enforceability of the remaining covenants, provisions, sections, subsections or subdivisions hereof.
18. Governing Law. This Agreement, and any dispute arising out of, relating to, or in connection with this Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware of any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. Each of the parties (a) consents to submit itself to the personal jurisdiction of the Court of Chancery of the State of Delaware (the “Chancery Court”) or, if, but only if, the Chancery Court lacks subject matter jurisdiction, any Federal court located in the State of Delaware with respect to any dispute arising out of, relating to or in connection with this Agreement or any transaction contemplated hereby, (b) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court and (c) agrees that it will not bring any action arising out of, relating to or in connection with this Agreement or any transaction contemplated by this Agreement, in any court other than any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or the transactions contemplated hereby in the Chancery Court or, if, but only if, the Chancery Court lacks subject matter jurisdiction, in any Federal court located in the State of Delaware, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
19. Counterparts. This Agreement may be executed and delivered in any number of counterparts (including by facsimile or electronic transmission), each of which will be deemed to be an original and all of which taken together will be deemed to constitute one and the same instrument, and each party may enter into this Agreement by executing a counterpart and delivering it to the other party (by personal delivery, facsimile, electronic transmission or otherwise).
20. Interpretation Not Affected by Headings. The division of this Agreement into articles, sections, paragraphs and subparagraphs and the insertion of a table of contents and headings are for convenience of reference only and do not affect the construction or interpretation of this Agreement. The terms “this Agreement”, “hereof”, “herein”, “hereunder” and similar expressions refer to this Agreement, and not to any particular article, section or other portion hereof. Unless something in the subject matter or context is clearly inconsistent therewith, references herein to an article, section, subsection,
paragraph, clause, subclause or schedule by number or letter or both are to that article, section, subsection, paragraph, clause or subclause in this Agreement.
IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first above written.
|
AUXILIUM PHARMACEUTICALS, INC. |
| |
|
|
| |
|
/s/ Adrian Adams |
| |
|
|
| |
|
Name: |
Adrian Adams |
|
|
|
|
|
|
Title: |
Chief Executive Officer and President |
|
|
|
| |
|
|
| |
|
COMPANY SHAREHOLDER: |
| |
|
|
| |
|
KINGSTOWN CAPITAL PARTNERS, LLC |
| |
|
|
| |
|
/s/ Michael Blitzer |
| |
|
|
| |
|
Name: |
Michael Blitzer |
|
|
|
|
|
|
Title: |
Managing Member |
|
|
|
|
|
|
|
|
|
|
Address: |
100 Park Avenue, Suite 2100 |
|
|
|
|
|
|
|
New York, NY 10017 |
|
Exhibit 99.3
VOTING AGREEMENT
THIS AGREEMENT is dated as of June 25, 2014 (this “Agreement”)
BETWEEN:
THE PERSONS NAMED ON THE SIGNATURE PAGE HERETO
(each such person a “Company Shareholder”)
AND:
Auxilium Pharmaceuticals, Inc., a corporation incorporated under the laws of Delaware
(“Auxilium”).
WHEREAS:
A. QLT Inc., a corporation incorporated under the laws of British Columbia (the “Company”), Auxilium, QLT Holding Corp., a corporation incorporated under the laws of Delaware and a wholly-owned subsidiary of the Company (“Holdco”) and QLT Acquisition Corp., a corporation incorporated under the laws of Delaware (“AcquireCo”), have entered into an Agreement and Plan of Merger (the “Merger Agreement”) providing for the merger of AcquireCo with and into Auxilium, with Auxilium being the surviving corporation, pursuant to which the shares of Auxilium will be converted into the right to receive common shares of the Company (such transactions, together with any other transaction contemplated by the Merger Agreement, the “Transaction”);
B. The Company Shareholders or their Affiliates (which includes for the purposes of this Agreement, any entity controlled by a Company Shareholder or an Affiliate of any entity controlled by a Company Shareholder) are the record or beneficial owners (as defined under Rule 13d-3 under the Securities Exchange Act of 1934, as amended) or have voting or dispositive power over the number of common shares without par value of the Company (the “Shares”), set forth next to each Company Shareholder’s name in Schedule A of this Agreement;
C. Auxilium requires the Company Shareholders to enter into this Agreement with respect to the Shares in order to set out the terms and conditions of the agreement of the Company Shareholders to support the Transaction and to vote the Shares in favour of the Transaction at any meeting of the Company’s shareholders called to consider such Transaction; and
D. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms by the Merger Agreement.
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the covenants and agreements herein contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
1. Agreement to Vote Securities. At any meeting of the shareholders of the Company, however called, or at any adjournment or postponement thereof, or in connection with
any written consent of the shareholders of the Company or in any other circumstances upon which a vote, consent or other approval of all or some of the shareholders of the Company is sought, each Company Shareholder shall vote (or cause to be voted) all of such Company Shareholder’s Shares and any other shares of capital stock of the Company owned, beneficially or of record as set forth next to its name in Schedule A of this Agreement (with respect to each Company Shareholder, its “Owned Securities”):
(a) in favor of approval of the Transaction, including without limitation in favor of approval of the QLT Shareholder Resolution, and any actions required in furtherance thereof; and
(b) against the following actions (other than the issuance of the Company Shares in connection with the Merger): (i) any acquisition proposal or merger, takeover bid, amalgamation, plan of arrangement, business combination or similar transaction involving the Company, other than the Transaction (an “Alternative Transaction”); (ii) any reorganization, recapitalization, dissolution, liquidation or winding up of the Company or any of its subsidiaries; (iii) any amendment of the Company’s notice of articles or articles that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction; (iv) any action or transaction that would result in a breach of any representation, warranty covenant or agreement of the Company under the Merger Agreement; or (v) any other action or transaction that would reasonably be regarded as being directed towards or likely to prevent, delay or impede the consummation of the Transaction.
2. Representations of the Company Shareholder. Each Company Shareholder, severally and not jointly, represents and warrants to Auxilium (and acknowledges that Auxilium is relying upon such representations and warranties) as follows:
(a) It or one of its Affiliates is the record or beneficial owner of the Owned Securities with good and marketable title thereto free and clear of any liens, pledges, mortgages, charges, restrictions, security interests, adverse claims and demands or rights of others of any nature or kind whatsoever (including without limitation any restriction on the right to vote, tender or otherwise transfer such Owned Securities).
(b) No person has any agreement or option, or any right or privilege, whether by law, pre-emptive or contractual, capable of becoming an agreement or option, for the exchange, acquisition or transfer from the Company Shareholder or any of its Affiliates of any of its Owned Securities or any interest therein or right thereto.
(c) It or one of its Affiliates has sole voting power and exclusive right of disposition with respect to its Owned Securities and sole power to agree to all matters set forth in this Agreement and neither the Company Shareholder nor any of its Affiliates has previously granted or agreed to grant a proxy or other right to vote in respect of such Owned Securities or entered into any voting trust, nor pooling or other agreement with respect to the right to vote, call meetings of
securityholders or give consents or approvals of any kind as to such Owned Securities except those which are no longer of force or effect.
(d) Neither it nor any of its Affiliates beneficially owns or controls any securities of the Company other than its Owned Securities.
(e) It has the legal capacity, power and authority to execute and deliver this Agreement and perform its obligations hereunder. This Agreement has been duly executed and delivered by the Company Shareholder and, assuming the due authorization, execution and delivery by Auxilium, this Agreement constitutes the legal, valid and binding obligation of the Company Shareholder, enforceable in accordance with its terms, subject to laws of general application and bankruptcy, insolvency and other similar laws affecting creditors’ rights generally and general principles of equity.
(f) Except as may be set forth in the Merger Agreement or as otherwise required by law (including, without limitation, filings as may be required under applicable securities laws), no filing with, and no permit, authorization, consent, or approval of, any Governmental Authority is necessary for the execution of this Agreement by the Company Shareholder and the performance by the Company Shareholder of its obligations under this Agreement, and (ii) none of the execution and delivery of this Agreement by the Company Shareholder, the performance by the Company Shareholder of its obligations under this Agreement or compliance by the Company Shareholder with any of the provisions of this Agreement shall (A) conflict with or result in any breach of the organizational documents, if applicable, of the Company Shareholder, (B) result in a material violation or material breach of, or constitute (with or without notice or lapse of time, or both) a default (or give rise to any third party right of termination, cancellation, amendment, or acceleration) under any of the terms, conditions, or provisions of any material note, bond, mortgage, indenture, license, contract, commitment, arrangement, understanding, agreement, or other instrument or obligation of any kind to which the Company Shareholder is a party, or (C) violate any order, writ, injunction, decree, judgment, statute, rule, or regulation applicable to the Company Shareholder, except in each case under clauses (B) and (C), where the absence of filing or authorization, conflict, violation, breach, or default would not materially impair or materially adversely affect the ability of such Company Shareholder to perform such Company Shareholder’s obligations hereunder on a timely basis.
(g) To the knowledge of the Company Shareholder, there is no private or governmental action, suit, proceeding, claim, arbitration or investigation pending before any Governmental Authority, or threatened against the Company Shareholder, any of its Affiliates or any of their respective properties that, individually or in the aggregate, could reasonably be expected to have a material adverse effect on the Company Shareholder’s ability to perform its obligations under this Agreement. To the knowledge of the Company Shareholder, there is no judgment, decree or order against the Company Shareholder or any of its
Affiliates that could prevent, enjoin, alter or materially delay any of the transactions contemplated by this Agreement, or that could reasonably be expected to have a material adverse effect on the Company Shareholder’s ability to perform its obligations under this Agreement.
3. Representations of Auxilium. Auxilium represents and warrants to the Company Shareholders that (and acknowledges that the Company Shareholders are relying upon such representations and warranties):
(a) Auxilium is, and will be as at the Effective Time, validly existing under the laws of Delaware;
(b) it has the requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder;
(c) it has full power and authority to make, enter into and carry out the terms of this Agreement;
(d) no consent, approval or authorization of, or declaration or filing with, or notice to, any governmental entity or stock exchange which has not been received or made is required by Auxilium in connection with the execution and delivery of this Agreement;
(e) there are no legal proceedings in progress or pending before any governmental entity, or to the knowledge of Auxilium, threatened against Auxilium or its Affiliates that would adversely affect in any manner the ability of Auxilium to enter into this Agreement or the Merger Agreement and to perform its obligations hereunder or thereunder.
4. No Action to Reduce Likelihood of Success or Delay. Each Company Shareholder will not, and will not permit any of its Affiliates to:
(a) solicit proxies or become a participant in a solicitation of proxies for any Alternative Transaction;
(b) assist any person, entity or group in taking or planning any action that would compete with, restrain or otherwise serve to interfere with or inhibit Auxilium in connection with the Transaction;
(c) solicit, initiate, knowingly encourage or knowingly facilitate a stockholders’ vote with respect to any Alternative Transaction;
(d) become a member of a “group” (as defined by the Securities Exchange Act of 1934, as amended) or act jointly or in concert (as “acting jointly or in concert” is interpreted under applicable Canadian securities Laws) with respect to any voting securities of the Company with respect to any Alternative Transaction;
(e) take any other action of any kind that might reasonably be regarded as likely to reduce the success of, or delay or interfere or compete with the completion of, the proposed Transaction or any other transaction contemplated by the Merger Agreement;
(f) solicit, initiate, encourage or facilitate any QLT Acquisition Proposal;
(g) participate in any discussions, conversations, negotiations or other communications with any person with respect to a QLT Acquisition Proposal; or
(h) furnish any information to any person in connection with a proposed QLT Acquisition Proposal or otherwise assist, facilitate or encourage the making of, or cooperate in any way regarding, any QLT Acquisition Proposal.
5. Covenants of Company Shareholders. Except with the prior written consent of Auxilium, each Company Shareholder and/or any of its Affiliates agrees as follows:
(a) No later than one (1) Business Day before the date of any meeting of the shareholders of the Company, each Company Shareholder shall deliver or cause to be delivered to the Company, with a copy to Auxilium concurrently, a duly executed proxy or proxies in respect of the Owned Securities directing those individuals as may be designated by the Company in the Joint Proxy Statement/Circular to vote the Owned Securities in accordance with paragraph 1, and each such proxy or proxies shall not be revoked without the written consent of Auxilium.
(b) Each Company Shareholder shall not (i) directly or indirectly, sell, transfer, tender, pledge, hedge, encumber, gift, assign or otherwise dispose of or exchange any or all of its Owned Securities or enter into any contract, option, agreement, arrangement or understanding (including any profit sharing agreement) in connection therewith (whether by actual disposition, derivative transaction or effective economic disposition through cash settlement), (ii) grant any proxies or powers of attorney, or any other authorization or consent with respect to any or all of such Company Shareholder’s Owned Securities or (iii) deposit any of such Company Shareholder’s Owned Securities into a voting trust or enter into a voting agreement with respect to any of such Company Shareholder’s Owned Securities; provided that, the Company Shareholder may transfer Shares to another Company Shareholder or to a corporation or other entity wholly owned or controlled by a Company Shareholder or an Affiliate of a Company Shareholder, provided that (1) such transfer shall not relieve or release the Company Shareholder of or from its obligations under this Agreement, including, without limitation the obligation of the Company Shareholder to vote or cause to be voted all its Owned Securities in favour of the Transaction, (2) prompt written notice of such transfer is provided to Auxilium, (3) the transferee agrees to be bound by the terms hereof pursuant to documentation approved in writing by Auxilium in advance of such transfer and (4) the transferee continues to be a Company Shareholder or a corporation or
other entity wholly owned or controlled by a Company Shareholder or an Affiliate of a Company Shareholder, at all times prior to the Effective Time.
(c) Each Company Shareholder agrees with, and covenants to, Auxilium that (i) this Agreement and the obligations hereunder shall attach to the Company Shareholder’s Owned Securities and shall be binding upon any person or entity to which legal or beneficial ownership shall pass, whether by operation of law or otherwise, including, without limitation, such Company Shareholder’s successors or assigns and (ii) the Company Shareholder shall not request that the Company register the transfer (book-entry or otherwise) of any certificate or uncertificated interest representing any or all of the Company Shareholder’s Owned Securities, unless such transfer is made in compliance with this Agreement and such Company Shareholder shall promptly following the date hereof authorize and instruct the Company to instruct its transfer agent to enter a stop transfer order with respect to all of its Owned Securities with respect to any transfer not permitted hereunder.
(d) Each Company Shareholder hereby covenants and agrees that it will not exercise any rights of appraisal or rights of dissent provided under any applicable laws or otherwise in connection with the Transaction at any shareholder meeting in connection therewith.
(e) Each Company Shareholder hereby agrees not to commence or join in, and agrees to take all actions necessary to opt out of any class, in any proceeding asserting a claim, derivative or otherwise, against Auxilium, Holdco, AcquireCo, or the Company or any of their respective successors or Affiliates (x) challenging the validity of, or seeking to enjoin in whole or in part the operation of this Agreement or the Merger Agreement or (y) alleging oppression or a breach of any fiduciary duty of any person in connection with the negotiation and entry into the Merger Agreement.
(f) In the event any Company Shareholder becomes the record or beneficial owner of (i) any common shares of the Company or any other securities of the Company, (ii) any securities which may be converted into or exchanged for such shares or other securities or (iii) any securities issued in replacement of, or as a dividend or distribution on, or otherwise in respect of, such shares or other securities (collectively, “Additional Securities”), the terms of this Agreement shall apply to any of such Additional Securities as though owned by such Company Shareholder on the date of this Agreement.
(g) Each Company Shareholder is entering into this Agreement solely in its capacity as the record or beneficial owner of its Owned Securities. Nothing contained in this Agreement shall limit the rights and obligations of any Company Shareholder, any of its Affiliates, representatives or any employee of any of its Affiliates in his or her capacity as a director or officer of the Company, and the agreements set forth herein shall in no way restrict any director or officer of the Company in the exercise of his or her fiduciary duties as a director or officer of
the Company in his or her capacity as such. Each Company Shareholder shall have no liability to Auxilium or any of its Affiliates under this Agreement as a result of any action or inaction by such Company Shareholder acting in his capacity as a director or officer of the Company.
6. Other Covenants. The Company Shareholder also agrees, severally and not jointly to the details of this Agreement being set out in any information circular or disclosure document produced by the Company or Auxilium in connection with the Transaction and to this Agreement being available for public inspection to the extent required by law.
7. Auxilium Acknowledgements. Auxilium acknowledges that, if any Company Shareholder is also a director, officer or employee of the Company or any of its subsidiaries, that the provisions of this Agreement shall bind such Company Shareholder solely in his or her capacity as a shareholder of the Company and shall not be deemed or interpreted to bind any such Company Shareholder in his or her capacity as a director, officer or employee of the Company or any of its subsidiaries.
8. Termination. Unless otherwise provided for herein, this Agreement shall terminate on the earlier of: (i) the consummation of the Transaction and (ii) termination of the Merger Agreement.
9. Termination by the Company Shareholder or Auxilium. This Agreement may be terminated by notice in writing:
(a) at any time prior to the Effective Time, by the mutual agreement of the parties;
(b) by the Company Shareholder, if the Merger Effective Time has not occurred by December 31, 2014; or
(c) by the Company Shareholder, if the Merger Agreement is amended by the parties thereto in a manner that results in an increase in the Equity Exchange Ratio.
10. Specific Performance. The parties agree that irreparable harm would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached for which money damages would not be an adequate remedy at Law. It is accordingly agreed that the parties hereto will be entitled to an injunction or injunctions and other equitable relief to prevent breaches of this Agreement, any requirement for the securing or posting of any bond in connection with the obtaining of any such injunctive or other equitable relief hereby being waived.
11. No Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Auxilium any direct or indirect ownership or incidence of ownership at law or in equity with respect to any of the Owned Securities or any right or entitlement to acquire or become the owner at law or in equity of the Owned Securities. Except as otherwise set forth in this Agreement, any rights, ownership and economic benefits of and relating to the Owned Securities shall remain vested in and belong to the Company Shareholders and their Affiliates, as the case may be. Auxilium shall have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or
operations of the Company or exercise any power or authority to direct any Company Shareholder or his or her Affiliates in the voting of any of the Owned Securities, except as otherwise provided herein, or in the performance of the Company Shareholder’s and its Affiliates’ duties or responsibilities as a Company Shareholder of the Company.
12. Successors and Assigns. The provisions of this Agreement shall be binding upon and enure to the benefit of the parties hereto and their respective successors and permitted assigns, provided that no party may assign, delegate or otherwise transfer any of its or his rights, interests or obligations under this Agreement without the prior written consent of the other party, except that Auxilium may assign, delegate or otherwise transfer any of its rights, interests or obligations under this Agreement to a direct or indirect subsidiary, without reducing its own obligations hereunder, without the prior consent of the Company Shareholders.
13. Confidentiality. Each Company Shareholder shall maintain in confidence the matters referred to in this Agreement and shall not make any public disclosure, except to the extent required by applicable law or the requirements of any securities regulatory authority or stock exchange, of the terms of this Agreement without the consent of Auxilium, such consent not to be unreasonably withheld.
14. Entire Agreement. This Agreement supersedes all prior agreements among the parties hereto with respect to the subject matter hereof and contains the entire agreement among the parties with respect to the subject matter hereof. This Agreement may not be modified or waived, except expressly by an instrument in writing signed by all the parties hereto. No waiver of any provision hereof by any party shall be deemed a waiver by any other party nor shall any such waiver be deemed a continuing waiver of any matter by such party.
15. Notice. Any demand, notice or other communication to be given in connection with this Agreement must be given in writing and will be given by personal delivery or by electronic means of communication addressed to the recipient as follows:
|
if to any Company Shareholder: |
|
The addresses set out on the last page of this Agreement |
|
|
|
|
|
if to Auxilium: |
|
The addresses set out for Auxilium in the Merger Agreement |
Any demand, notice or other communication given by personal delivery will be conclusively deemed to have been given on the day of actual delivery thereof and, if given by electronic communication, on the day of transmittal thereof if given during the normal business hours of the recipient and on the business day during which such normal business hours next occur if not given during such hours on any day.
16. Further Assurances. Each of the parties hereto agrees to execute such further and other deeds, documents and assurances and to do such further and other acts as may be necessary to carry out the true intent and meaning of this Agreement fully and effectually.
17. Severability. Each of the covenants, provisions, sections, subsections and other subdivisions hereof is severable from every other covenant, provision, section, subsection and subdivision and the invalidity or unenforceability of any one or more covenants, provisions, sections, subsections and other subdivisions hereof shall not affect the validity or enforceability of the remaining covenants, provisions, sections, subsections or subdivisions hereof.
18. Governing Law. This Agreement, and any dispute arising out of, relating to, or in connection with this Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware of any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. Each of the parties (a) consents to submit itself to the personal jurisdiction of the Court of Chancery of the State of Delaware (the “Chancery Court”) or, if, but only if, the Chancery Court lacks subject matter jurisdiction, any Federal court located in the State of Delaware with respect to any dispute arising out of, relating to or in connection with this Agreement or any transaction contemplated hereby, (b) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court and (c) agrees that it will not bring any action arising out of, relating to or in connection with this Agreement or any transaction contemplated by this Agreement, in any court other than any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or the transactions contemplated hereby in the Chancery Court or, if, but only if, the Chancery Court lacks subject matter jurisdiction, in any Federal court located in the State of Delaware, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
19. Counterparts. This Agreement may be executed and delivered in any number of counterparts (including by facsimile or electronic transmission), each of which will be deemed to be an original and all of which taken together will be deemed to constitute one and the same instrument, and each party may enter into this Agreement by executing a counterpart and delivering it to the other party (by personal delivery, facsimile, electronic transmission or otherwise).
20. Interpretation Not Affected by Headings. The division of this Agreement into articles, sections, paragraphs and subparagraphs and the insertion of a table of contents and headings are for convenience of reference only and do not affect the construction or interpretation of this Agreement. The terms “this Agreement”, “hereof”, “herein”, “hereunder” and similar expressions refer to this Agreement, and not to any particular article, section or other portion hereof. Unless something in the subject matter or context is clearly inconsistent therewith, references herein to an article, section, subsection,
paragraph, clause, subclause or schedule by number or letter or both are to that article, section, subsection, paragraph, clause or subclause in this Agreement.
IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first above written.
|
AUXILIUM PHARMACEUTICALS, INC. |
|
|
|
|
|
/s/ Adrian Adams |
|
|
|
|
|
Name: Adrian Adams |
|
|
|
|
|
Title: Chief Executive Officer and President |
|
COMPANY SHAREHOLDER:
VISIUM BALANCED MASTER FUND, LTD.
By: Visium Asset Management, LP
Its: Investment Manager
|
/s/ Mark Gottlieb |
|
|
|
|
|
Name: Mark Gottlieb |
|
|
|
|
|
Title: Authorized Signatory |
|
Address: c/o Visium Asset Management, LP
888 Seventh Avenue, 22nd Floor
New York, NY 10019
Attention: General Counsel
legal@visiumfunds.com